Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Liver crawled time : 20:20 save search
89bio Announces Additional Data from the ENLIVEN Phase 2b Trial of Pegozafermin in Patients with Compensated Cirrhotic (F4) Nonalcoholic Steatohepatitis (NASH) at AASLD The Liver Meeting® 2023
Published: 2023-11-12 (Crawled : 20:20) - globenewswire.com
ETNB | $9.31 2.53% 2.47% 580K
|
Health Technology
| Email alert
Add to watchlist
meeting liver trial
89bio Presents Additional Exploratory Analyses from the Phase 1b/2a NASH Study of Pegozafermin at AASLD The Liver Meeting® 2022
Published: 2022-11-05 (Crawled : 20:20) - globenewswire.com
ETNB | $9.31 2.53% 2.47% 580K
|
Health Technology
| Email alert
Add to watchlist
meeting liver nash study phase 2b
REGENXBIO Presents Positive Interim Data from Phase II ALTITUDE™ Trial of RGX-314 for the Treatment of Diabetic Retinopathy Using Suprachoroidal Delivery
Published: 2022-02-12 (Crawled : 20:20) - prnewswire.com
RGNX | $15.68 -0.06% -0.06% 440K
|
Health Technology
| Email alert
Add to watchlist
CLSD | News P | $1.41 7.63% 7.09% 300K
|
Health Technology
| Email alert
Add to watchlist
rgx-314 treatment liver trial positive diabetic diabetes
Red Cross delivering comfort and help after deadly tornadoes
Published: 2021-12-12 (Crawled : 20:20) - prnewswire.com
TAK | News | $13.36 0.91% -0.52% 1.6M
|
Health Technology
|
| O: -0.59%
H: 0.0%
C: 0.0%
NOW | $721.95 1.13% 0.0% 1.5M
|
Technology Services
|
| O: -0.78%
H: 2.56%
C: 1.75%
R | News | $109.0 0.27% 0.0% 440K
|
Finance
|
| O: -1.06%
H: 3.81%
C: 2.81%
NEE | $65.31 1.57% 0.0% 14M
|
Utilities
|
| O: 0.2%
H: 2.06%
C: 1.64%
LMT | $461.33 -0.55% 0.12% 1.8M
|
Electronic Technology
|
| O: -0.36%
H: 0.7%
C: 0.33%
KMB | $128.93 1.66% -0.01% 2.7M
|
Consumer Non-Durables
|
| O: -0.32%
H: 2.73%
C: 2.4%
F | News | $12.88 6.1% -0.04% 86M
|
Consumer Durables
|
| O: 7.34%
H: 0.0%
C: 0.0%
EIX | $70.66 1.04% 0.0% 1.4M
|
Utilities
|
| O: -0.39%
H: 0.66%
C: 0.15%
AVB 4 | $186.87 1.49% 0.0% 630K
|
Finance
|
| O: -0.46%
H: 1.86%
C: 1.33%
MO 4 | $42.57 1.14% 0.12% 11M
|
Consumer Non-Durables
|
| O: 0.02%
H: 1.04%
C: 0.73%
KHC | $38.15 0.98% 0.97% 6.9M
|
Consumer Non-Durables
|
| O: 2.03%
H: 1.67%
C: 0.97%
LHCG | $169.81 0.47% -0.03% 0
|
Health Services
|
| O: 0.51%
H: 1.23%
C: -1.06%
FOXA | News | $31.4 0.03% 0.03% 2.4M
|
Consumer Services
|
| O: -1.3%
H: 0.55%
C: -0.3%
FOX | News | $28.97 0.35% 0.35% 830K
|
Consumer Services
|
| O: -1.02%
H: 0.56%
C: -0.41%
liver
Medtronic announces early data for the Intrepid™ transcatheter mitral valve replacement (TMVR) system using new transfemoral delivery system
Published: 2021-11-06 (Crawled : 20:20) - prnewswire.com
MDT | $80.57 1.37% 0.0% 5M
|
Health Technology
| Email alert
Add to watchlist
liver system
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.565 105.2% 51.27% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.91 48.81% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.